Changing epidemiology, implications, and recommendations for Hepatitis C in Women of Childbearing Age and During Pregnancy.
Despite remarkable advances in HCV treatment with DAAs, HCV remains a public health concern worldwide, and rising prevalence of HCV infection has been cited in women of childbearing age. Implications of active HCV on pregnancy include association with cholestasis of pregnancy as well as risk of mother-to-child transmission. Recent updates have increased recommendations for universal screening during pregnancy. Treatment of HCV in the pregnancy context is currently being investigated.